Predicting Risk For Recurrence For Patients With DCIS Breast Cancer

[News]

In a significant advance for patients with ductal carcinoma in situ, researchers have developed and prospectively validated a multigene test to identify the risk for recurrence of breast cancer...

More... (http://www.medicalnewstoday.com/releases/238754.php)